Mirum Pharmaceuticals, Inc. (MIRM)
USD 43.69
(0.62%)
USD 43.69
(0.62%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 248.48 Million USD | 26.67% |
| 2022 | 195.9 Million USD | 2.76% |
| 2021 | 190.64 Million USD | 82.8% |
| 2020 | 104.29 Million USD | 90.52% |
| 2019 | 54.74 Million USD | 1777.33% |
| 2018 | 2.91 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 81.72 Million USD | 5.16% |
| 2024 Q1 | 77.86 Million USD | 1.08% |
| 2023 Q4 | 77.02 Million USD | 22.95% |
| 2023 FY | 248.16 Million USD | 26.67% |
| 2023 Q3 | 62.64 Million USD | 13.99% |
| 2023 Q2 | 54.95 Million USD | 2.22% |
| 2023 Q1 | 53.76 Million USD | -6.61% |
| 2022 Q2 | 46.4 Million USD | 7.4% |
| 2022 Q1 | 43.2 Million USD | -7.7% |
| 2022 Q3 | 48.73 Million USD | 5.02% |
| 2022 FY | 195.9 Million USD | 2.76% |
| 2022 Q4 | 57.57 Million USD | 18.15% |
| 2021 Q1 | 47.61 Million USD | 28.85% |
| 2021 Q2 | 48.4 Million USD | 1.66% |
| 2021 Q3 | 47.82 Million USD | -1.19% |
| 2021 Q4 | 46.81 Million USD | -2.12% |
| 2021 FY | 190.64 Million USD | 82.8% |
| 2020 FY | 104.29 Million USD | 90.52% |
| 2020 Q4 | 36.95 Million USD | 70.16% |
| 2020 Q3 | 21.71 Million USD | -7.97% |
| 2020 Q2 | 23.59 Million USD | 7.1% |
| 2020 Q1 | 22.03 Million USD | 18.08% |
| 2019 Q3 | 15.86 Million USD | 13.06% |
| 2019 FY | 54.74 Million USD | 1777.33% |
| 2019 Q1 | 6.18 Million USD | -76.25% |
| 2019 Q4 | 18.65 Million USD | 17.59% |
| 2019 Q2 | 14.03 Million USD | 126.94% |
| 2018 Q4 | 26.03 Million USD | 39952.31% |
| 2018 FY | 2.91 Million USD | 0.0% |
| 2018 Q3 | 65 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -2316.033% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -8930.759% |
| XOMA Corporation | 46.46 Million USD | -434.81% |
| Mesoblast Limited | 5.9 Million USD | -4110.251% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -47.527% |
| Aptorum Group Limited | 10.56 Thousand USD | -2351679.292% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -3976.526% |
| HilleVax, Inc. | 133.34 Million USD | -86.35% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | 4.302% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -1686.452% |
| Precision BioSciences, Inc. | 92.46 Million USD | -168.744% |
| Dyadic International, Inc. | 9.15 Million USD | -2614.927% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -2887.006% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -57.457% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -1016.654% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -737.171% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -113.381% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | 22.771% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -89.407% |
| IGM Biosciences, Inc. | 265.59 Million USD | 6.439% |
| Opthea Limited | 191.96 Million USD | -29.443% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -300.156% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -1285.189% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -104.674% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -194.687% |
| NextCure, Inc. | 67.63 Million USD | -267.386% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -3591.192% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -316.417% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -428.633% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -1.422% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -707.543% |
| Senti Biosciences, Inc. | 94.7 Million USD | -162.382% |
| Apollomics, Inc. | 54.14 Million USD | -358.975% |
| PureTech Health plc | 144.59 Million USD | -71.849% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -1849.545% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -193.32% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -1.789% |
| ChromaDex Corporation | 56.37 Million USD | -340.747% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -2713.751% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -23.556% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -8.662% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -2989.927% |
| Gritstone bio, Inc. | 148.37 Million USD | -67.475% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -1483.763% |
| Fate Therapeutics, Inc. | 254.04 Million USD | 2.187% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -44.553% |
| Fortress Biotech, Inc. | 200.19 Million USD | -24.123% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -375.568% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -691.946% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -0.547% |
| Celcuity Inc. | 66.23 Million USD | -275.189% |
| ContextLogic Inc. | 387 Million USD | 35.791% |
| GH Research PLC | 41.22 Million USD | -502.807% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -658.838% |
| Cassava Sciences, Inc. | 105.95 Million USD | -134.519% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -860.418% |
| ImmuCell Corporation | 9.61 Million USD | -2483.754% |
| Amarin Corporation plc | 272.35 Million USD | 8.763% |
| TG Therapeutics, Inc. | 198.47 Million USD | -25.199% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -131.105% |
| Acelyrin, Inc. | 422.06 Million USD | 41.125% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -645.54% |
| Seer, Inc. | 110.49 Million USD | -124.897% |
| Novavax, Inc. | 779.12 Million USD | 68.107% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -48.063% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 92.367% |
| AnaptysBio, Inc. | 181.56 Million USD | -36.857% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -760.479% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -210.1% |
| AbCellera Biologics Inc. | 275.23 Million USD | 9.717% |
| CorMedix Inc. | 48.95 Million USD | -407.558% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -124.133% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -1288.788% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 91.174% |
| Aptose Biosciences Inc. | 52.35 Million USD | -374.614% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -1624.376% |
| Soligenix, Inc. | 7.79 Million USD | -3087.697% |
| Century Therapeutics, Inc. | 56.07 Million USD | -343.168% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | 44.252% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -1179.65% |
| Kura Oncology, Inc. | 165.8 Million USD | -49.869% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -95.565% |
| Ardelyx, Inc. | 169.93 Million USD | -46.224% |
| Ainos, Inc. | 12.95 Million USD | -1818.439% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -117.008% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -9913.1% |
| Prothena Corporation plc | 282.4 Million USD | 12.01% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -130.728% |
| Autolus Therapeutics plc | 196.72 Million USD | -26.312% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -193.524% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -24.231% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -1181.995% |
| Celularity Inc. | 215.05 Million USD | -15.545% |
| Rallybio Corporation | 78.93 Million USD | -214.814% |
| GRI Bio, Inc. | 11.33 Million USD | -2093.195% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -3421.819% |
| Omeros Corporation | 94.75 Million USD | -162.255% |
| INmune Bio, Inc. | 29.89 Million USD | -731.178% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -44.007% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -516.379% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -1455.062% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -1478.555% |
| Humacyte, Inc. | 23.49 Million USD | -957.535% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | 9.867% |
| Coherus BioSciences, Inc. | 301.45 Million USD | 17.569% |
| Immunocore Holdings plc | 308.04 Million USD | 19.332% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -7230.059% |
| Verastem, Inc. | 92.08 Million USD | -169.85% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -33.794% |
| Histogen Inc. | 14.27 Million USD | -1641.094% |
| Surrozen, Inc. | 18.55 Million USD | -1239.563% |
| Blueprint Medicines Corporation | 722.86 Million USD | 65.624% |
| Organovo Holdings, Inc. | 14.91 Million USD | -1566.034% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -4781.679% |
| IO Biotech, Inc. | 91.44 Million USD | -171.742% |
| MEI Pharma, Inc. | 34.78 Million USD | -614.357% |
| GT Biopharma, Inc. | 13.57 Million USD | -1730.355% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -39.494% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -412.899% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -232.827% |
| Summit Therapeutics Inc. | 87.68 Million USD | -183.385% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -743.222% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -54.783% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -1517.075% |
| Turnstone Biologics Corp. | 78.33 Million USD | -217.201% |
| Pulmatrix, Inc. | 22.03 Million USD | -1027.548% |
| Synaptogenix, Inc. | 8.31 Million USD | -2888.855% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -1603.613% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | 1.805% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -179.622% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | 54.948% |
| Cytokinetics, Incorporated | 173.61 Million USD | -43.129% |
| Exelixis, Inc. | 1.58 Billion USD | 84.34% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -7.084% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | 70.944% |
| Evogene Ltd. | 27.79 Million USD | -794.167% |
| Replimune Group, Inc. | 234.77 Million USD | -5.842% |
| PDS Biotechnology Corporation | 43.04 Million USD | -477.274% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -3130.385% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -260.856% |
| ESSA Pharma Inc. | 32.13 Million USD | -673.287% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -1418.861% |
| BioLineRx Ltd. | 50.8 Million USD | -389.132% |
| Avid Bioservices, Inc. | 25.99 Million USD | -855.874% |
| Insmed Incorporated | 949.26 Million USD | 73.823% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -629.027% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | 1.609% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -658.977% |
| MediWound Ltd. | 18.86 Million USD | -1216.986% |
| MiMedx Group, Inc. | 229.72 Million USD | -8.167% |
| OmniAb, Inc. | 83.89 Million USD | -196.19% |
| Alector, Inc. | 248.8 Million USD | 0.126% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -6.052% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 81.058% |
| Mereo BioPharma Group plc | 35.84 Million USD | -593.29% |
| Zai Lab Limited | 547.47 Million USD | 54.612% |
| Revance Therapeutics, Inc. | 398.65 Million USD | 37.668% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -8.06% |
| Aura Biosciences, Inc. | 84.99 Million USD | -192.371% |
| Immunic, Inc. | 99.22 Million USD | -150.435% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -2.613% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -56.271% |
| Veracyte, Inc. | 357.93 Million USD | 30.577% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 97.244% |
| FibroGen, Inc. | 398.11 Million USD | 37.583% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -1648.691% |
| Allakos Inc. | 196.05 Million USD | -26.744% |
| scPharmaceuticals Inc. | 65.17 Million USD | -281.247% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -118.993% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | 32.588% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -3507.592% |
| NLS Pharmaceutics AG | 11.8 Million USD | -2004.579% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -3387.207% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | 21.499% |
| Precigen, Inc. | 84.18 Million USD | -195.184% |
| Fortrea Holdings Inc. | 457.3 Million USD | 45.662% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -357.808% |
| Incyte Corporation | 1.19 Billion USD | 79.127% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -2400.482% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -74.424% |
| XBiotech Inc. | 37.51 Million USD | -562.461% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -139.725% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -260.856% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -922.31% |
| CRISPR Therapeutics AG | 463.49 Million USD | 46.388% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -43.743% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -564.267% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -1103.395% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -74.917% |
| Agenus Inc. | 78.18 Million USD | -217.83% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -1874.188% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -150.809% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -124.438% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 74.068% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -761.463% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -3592.955% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | 42.298% |
| UroGen Pharma Ltd. | 138.88 Million USD | -78.913% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -1013.885% |
| Sutro Biopharma, Inc. | 243 Million USD | -2.255% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -4392.702% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -866.582% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -876.036% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -101.119% |
| Chimerix, Inc. | 93.38 Million USD | -166.08% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -199.193% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -367.732% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -4936.661% |
| Pluri Inc. | 22.48 Million USD | -1005.378% |
| Cue Biopharma, Inc. | 19.54 Million USD | -1171.564% |
| MeiraGTx Holdings plc | 151.07 Million USD | -64.477% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -1448.397% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -3155.524% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -186.063% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -2839.746% |
| CalciMedica, Inc. | 21.81 Million USD | -1038.97% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -45.065% |
| Sana Biotechnology, Inc. | 294.94 Million USD | 15.749% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -618.696% |
| NLS Pharmaceutics AG | 11.8 Million USD | -2004.579% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -242.503% |
| Nutriband Inc. | 5.73 Million USD | -4233.583% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -469.759% |
| Vor Biopharma Inc. | 126.03 Million USD | -97.157% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 79.104% |
| ProKidney Corp. | 151.52 Million USD | -63.995% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -235.004% |
| Daré Bioscience, Inc. | 33.6 Million USD | -639.344% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | 59.544% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -3230.505% |
| Bicycle Therapeutics plc | 216.92 Million USD | -14.552% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -64.89% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -552.682% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | 50.179% |
| Atai Life Sciences N.V. | 125.78 Million USD | -97.551% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -204.374% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -205.235% |
| MediciNova, Inc. | 10.9 Million USD | -2179.66% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -92.896% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -3322.938% |
| GeoVax Labs, Inc. | 6.02 Million USD | -4026.235% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -61.722% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | 47.836% |
| Biomea Fusion, Inc. | 126.13 Million USD | -97.002% |
| RenovoRx, Inc. | 11.39 Million USD | -2080.493% |
| Erasca, Inc. | 141.52 Million USD | -75.58% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -30.038% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -800.91% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -86.009% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | 5.174% |
| bluebird bio, Inc. | 240.23 Million USD | -3.437% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -19.469% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -242.432% |
| Imunon, Inc. | 20.31 Million USD | -1123.455% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 85.77% |
| BioAtla, Inc. | 129.68 Million USD | -91.607% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -192.622% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -495.069% |
| DBV Technologies S.A. | 92.16 Million USD | -169.628% |
| Fortress Biotech, Inc. | 200.19 Million USD | -24.123% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -1.359% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -123.52% |
| aTyr Pharma, Inc. | 12.97 Million USD | -1814.547% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | 2.463% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -2921.211% |
| Galecto, Inc. | 35.62 Million USD | -597.474% |
| Akari Therapeutics, Plc | 16.8 Million USD | -1378.573% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -10827.541% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | 16.982% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -43.744% |
| Entera Bio Ltd. | 8.86 Million USD | -2704.616% |
| Travere Therapeutics, Inc. | 472 Million USD | 47.354% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -570.432% |
| Xencor, Inc. | 306.97 Million USD | 19.053% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -359.484% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -300.259% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -1112.74% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -29.559% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -3592.955% |
| Portage Biotech Inc. | 18.19 Million USD | -1265.399% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -3322.938% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -136.744% |
| OncoCyte Corporation | 25.63 Million USD | -869.259% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -2068.872% |
| Purple Biotech Ltd. | -22.46 Million USD | 1206.018% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -1407.822% |
| Onconetix, Inc. | 34.9 Million USD | -611.851% |
| MacroGenics, Inc. | 217.21 Million USD | -14.398% |
| Tharimmune, Inc. | 9.45 Million USD | -2528.062% |
| Genprex, Inc. | 31.06 Million USD | -700.014% |
| Apogee Therapeutics, Inc. | 93 Million USD | -167.184% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -32.509% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -739.32% |
| Prime Medicine, Inc. | 186.63 Million USD | -33.139% |
| Aditxt, Inc. | 25.95 Million USD | -857.54% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -32382.222% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -4462.01% |
| OKYO Pharma Limited | 8243.57 USD | -3014237.235% |
| Savara Inc. | 15.74 Million USD | -1478.209% |
| Curis, Inc. | 58.35 Million USD | -325.823% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -4779.521% |
| Adagene Inc. | 41.83 Million USD | -494.026% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -819.58% |
| BeiGene, Ltd. | 3.28 Billion USD | 92.439% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -13.037% |
| GlycoMimetics, Inc. | 39.28 Million USD | -532.524% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -44.596% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -5389.075% |
| SciSparc Ltd. | 9.01 Million USD | -2657.618% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -5389.075% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -483.184% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -2770.494% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -976.241% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -1629.702% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | 15.972% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -272.542% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 86.196% |
| ADMA Biologics, Inc. | 66.58 Million USD | -273.185% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -90.759% |
| Clene Inc. | 41.07 Million USD | -504.994% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -472.371% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -19.391% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -353.48% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | 29.416% |
| Adicet Bio, Inc. | 152.03 Million USD | -63.439% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -636.744% |
| Absci Corporation | 73.66 Million USD | -237.318% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -3299.257% |
| Quantum-Si incorporated | 111.65 Million USD | -122.543% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -1604.575% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -593.677% |
| Surrozen, Inc. | 18.55 Million USD | -1239.563% |
| Generation Bio Co. | 144.46 Million USD | -72.004% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -199.276% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -65.069% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -187.403% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -206.542% |
| Invivyd, Inc. | 205.75 Million USD | -20.769% |
| Cingulate Inc. | 22.75 Million USD | -991.818% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -244.363% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -2549.559% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -2917.862% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -230.2% |
| Jaguar Health, Inc. | 42.01 Million USD | -491.429% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -2315.563% |
| 2seventy bio, Inc. | 289.88 Million USD | 14.281% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -659.557% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -142.291% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | 67.048% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -1840.125% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -576.492% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -139.618% |
| Kronos Bio, Inc. | 128.11 Million USD | -93.953% |
| Innoviva, Inc. | 132.15 Million USD | -88.03% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -195.567% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -88.0% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -45.931% |
| Vir Biotechnology, Inc. | 767.72 Million USD | 67.633% |
| Evaxion Biotech A/S | 22.27 Million USD | -1015.802% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -83.327% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -5.793% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -210.825% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 3416.725% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -456.315% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -300.311% |
| Clearmind Medicine Inc. | 8.74 Million USD | -2742.684% |
| AlloVir, Inc. | 180.93 Million USD | -37.338% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -124.309% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | 4.215% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -8372.222% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -146.451% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -46.794% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -556.181% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -9.65% |
| ImmunityBio, Inc. | 362.87 Million USD | 31.522% |
| Korro Bio, Inc. | 84.53 Million USD | -193.952% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -55.513% |
| Kineta, Inc. | 21.15 Million USD | -1074.556% |
| Lantern Pharma Inc. | 17.87 Million USD | -1289.948% |
| BioVie Inc. | 31.95 Million USD | -677.738% |
| Codexis, Inc. | 66.51 Million USD | -273.567% |
| Celularity Inc. | 215.05 Million USD | -15.545% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -477.881% |
| Virax Biolabs Group Limited | 6.54 Million USD | -3695.427% |
| Kodiak Sciences Inc. | 277.32 Million USD | 10.397% |
| Cibus, Inc. | 320.3 Million USD | 22.421% |
| Annexon, Inc. | 143.72 Million USD | -72.894% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -984.679% |
| Moderna, Inc. | 6.39 Billion USD | 96.114% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | 68.126% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -94.754% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -38726.406% |
| Immix Biopharma, Inc. | 16.14 Million USD | -1439.479% |
| Eyenovia, Inc. | 25.4 Million USD | -878.055% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -77.094% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -73.391% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -37.059% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -4367.62% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -214.014% |
| Alkermes plc | 996.24 Million USD | 75.057% |
| Arcellx, Inc. | 200.19 Million USD | -24.121% |
| Moolec Science SA | 52.75 Million USD | -371.064% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -441.37% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -433.926% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -14.823% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -2395.621% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -164.148% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -412.634% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -2563.943% |
| Humacyte, Inc. | 23.49 Million USD | -957.535% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -306.44% |
| Geron Corporation | 70.44 Million USD | -252.762% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -251.997% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -1609.003% |
| Royalty Pharma plc | 862.4 Million USD | 71.186% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -998.122% |
| Notable Labs, Ltd. | 14.77 Million USD | -1582.39% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -19.574% |
| Structure Therapeutics Inc. | 102.77 Million USD | -141.78% |
| IN8bio, Inc. | 30.33 Million USD | -719.095% |
| 89bio, Inc. | 151.2 Million USD | -64.34% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -1068.425% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -143.588% |
| Acasti Pharma Inc. | 11.3 Million USD | -2098.823% |
| Genelux Corporation | 24.33 Million USD | -921.118% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -632.509% |
| Liquidia Corporation | 87.98 Million USD | -182.425% |
| Mustang Bio, Inc. | 48.5 Million USD | -412.338% |
| Immunovant, Inc. | 282.7 Million USD | 12.104% |
| Vericel Corporation | 142.04 Million USD | -74.943% |
| Quantum-Si incorporated | 111.65 Million USD | -122.543% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -1002.24% |
| XOMA Corporation | 46.46 Million USD | -434.81% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -267.859% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -984.106% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -1455.062% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 796.438% |
| Vaxcyte, Inc. | 468.04 Million USD | 46.909% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -433.903% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -3299.257% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -1464.201% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -752.245% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -705.24% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | 1.582% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -500.447% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -745.344% |
| PepGen Inc. | 84.76 Million USD | -193.147% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -738.612% |
| United Therapeutics Corporation | 885.1 Million USD | 71.925% |
| Solid Biosciences Inc. | 104.31 Million USD | -138.21% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -659.312% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -4367.62% |
| Immuneering Corporation | 58.41 Million USD | -325.401% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -4781.679% |
| Silo Pharma, Inc. | 3.92 Million USD | -6236.005% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -6203.551% |
| Belite Bio, Inc | 31.66 Million USD | -684.669% |
| Pharming Group N.V. | 225.49 Million USD | -10.199% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -922.31% |
| Bionomics Limited | 17.89 Billion USD | 98.611% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -202.313% |
| uniQure N.V. | 285.08 Million USD | 12.837% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -1323.435% |
| GeoVax Labs, Inc. | 6.02 Million USD | -4026.235% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -27.951% |
| Altimmune, Inc. | 30.55 Million USD | -713.225% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -2890.689% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 796.438% |
| Peak Bio, Inc. | 1249.13 USD | -19892865.504% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -1648.691% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -2695.466% |
| Benitec Biopharma Inc. | 22.38 Million USD | -1010.218% |
| Zura Bio Limited | 62.63 Million USD | -296.706% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | 41.894% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -1927067.675% |
| Compugen Ltd. | 43.97 Million USD | -465.12% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -21801.408% |
| argenx SE | 1.53 Billion USD | 83.796% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -235.252% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -985.247% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -2.179% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -770.578% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | 34.693% |
| PolyPid Ltd. | 21.04 Million USD | -1080.751% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -1426.72% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -2808.345% |
| Forte Biosciences, Inc. | 32.47 Million USD | -665.123% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -387.233% |
| Instil Bio, Inc. | 85.78 Million USD | -189.665% |
| Elevation Oncology, Inc. | 45.44 Million USD | -446.791% |
| Immunome, Inc. | 122.82 Million USD | -102.32% |
| Verona Pharma plc | 67.15 Million USD | -270.044% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -1410.715% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -859.973% |
| Shattuck Labs, Inc. | 93.61 Million USD | -165.44% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -251.455% |
| Design Therapeutics, Inc. | 78.19 Million USD | -217.802% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -185.485% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -1874.485% |
| Achilles Therapeutics plc | 75.25 Million USD | -230.196% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -388.392% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -275.935% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -359.118% |
| Beam Therapeutics Inc. | 554.19 Million USD | 55.162% |
| Moolec Science SA | 52.75 Million USD | -371.064% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -337.797% |
| AEON Biopharma, Inc. | 48.42 Million USD | -413.1% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -165.826% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -197.488% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | 44.902% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -182.727% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -87.461% |
| Athira Pharma, Inc. | 125.46 Million USD | -98.053% |
| HCW Biologics Inc. | 21.02 Million USD | -1081.732% |
| XOMA Corporation | 46.46 Million USD | -434.81% |
| NeurAxis, Inc. | 8.82 Million USD | -2716.953% |
| Lumos Pharma, Inc. | 38.66 Million USD | -542.672% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -859.973% |
| 180 Life Sciences Corp. | 13.47 Million USD | -1743.732% |
| Nektar Therapeutics | 190.9 Million USD | -30.165% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -770.578% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -837.608% |
| Arvinas, Inc. | 480 Million USD | 48.231% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -8372.222% |
| Palisade Bio, Inc. | 13.32 Million USD | -1765.533% |
| Nutriband Inc. | 5.73 Million USD | -4233.583% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -10827.541% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -346.497% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -447.224% |
| Merus N.V. | 200.49 Million USD | -23.938% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -140.423% |
| Neurogene Inc. | 55.58 Million USD | -347.059% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -2840.35% |
| CervoMed Inc. | 14.95 Million USD | -1561.271% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -156.942% |
| Sesen Bio, Inc. | 78.38 Million USD | -217.027% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -617.761% |
| Rezolute, Inc. | 70.38 Million USD | -253.033% |
| Clene Inc. | 41.07 Million USD | -504.994% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -1417.168% |
| BeyondSpring Inc. | 24.86 Million USD | -899.353% |
| Synlogic, Inc. | 58.53 Million USD | -324.535% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -1288.827% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -5431.812% |
| Peak Bio, Inc. | 1249.13 USD | -19892865.504% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -311.093% |
| Krystal Biotech, Inc. | 160.42 Million USD | -54.893% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | 8.182% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | 28.603% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -11421.541% |
| MannKind Corporation | 125.59 Million USD | -97.846% |
| Ikena Oncology, Inc. | 84.57 Million USD | -193.802% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -2475.816% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -177.328% |
| Gossamer Bio, Inc. | 183.75 Million USD | -35.225% |
| CohBar, Inc. | 12.38 Million USD | -1905.837% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -389.884% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -800.91% |
| Legend Biotech Corporation | 583.14 Million USD | 57.388% |
| Mural Oncology plc | 192.07 Million USD | -29.374% |
| Disc Medicine, Inc. | 91.12 Million USD | -172.69% |
| Champions Oncology, Inc. | 28.11 Million USD | -783.988% |
| REGENXBIO Inc. | 321.15 Million USD | 22.627% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -4534.922% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -345.672% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -537.795% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -117.292% |
| Vaxart, Inc. | 90.72 Million USD | -173.89% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -2816.535% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -480.662% |
| Cellectis S.A. | 97.32 Million USD | -155.332% |
| Longeveron Inc. | 21.25 Million USD | -1069.36% |
| Repare Therapeutics Inc. | 167.35 Million USD | -48.478% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 81.74% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -228.494% |
| Revolution Medicines, Inc. | 498.76 Million USD | 50.179% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -3635.553% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -465.339% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -233.14% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -256.845% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -2146.736% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 94.796% |
| Denali Therapeutics Inc. | 527.23 Million USD | 52.869% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -2770.494% |
| Veru Inc. | 101.34 Million USD | -145.184% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -961.601% |
| Cingulate Inc. | 22.75 Million USD | -991.818% |
| Passage Bio, Inc. | 108.38 Million USD | -129.257% |
| Context Therapeutics Inc. | 25.07 Million USD | -891.077% |
| Exicure, Inc. | 14.07 Million USD | -1665.338% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -20.588% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -473.864% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -2607.651% |
| Nuvalent, Inc. | 149.49 Million USD | -66.222% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -2980.352% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -139.739% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -1058.511% |
| OmniAb, Inc. | 83.89 Million USD | -196.19% |
| Anew Medical, Inc. | 1.3 Million USD | -19002.181% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -658.421% |
| Lipocine Inc. | 15.08 Million USD | -1547.79% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -262.689% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -226.307% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -516.379% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -116.373% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -1010.119% |
| Sage Therapeutics, Inc. | 664.14 Million USD | 62.585% |
| Ocugen, Inc. | 71.56 Million USD | -247.212% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -164.727% |
| Q32 Bio Inc. | 92.68 Million USD | -168.115% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -1073.557% |
| Alumis Inc. Common Stock | 158.17 Million USD | -57.099% |
| Equillium, Inc. | 50.6 Million USD | -391.027% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -298.181% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -1686.976% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -1217.188% |
| Dominari Holdings Inc. | 23.83 Million USD | -942.538% |
| Edesa Biotech, Inc. | 9.22 Million USD | -2594.303% |
| vTv Therapeutics Inc. | 11.9 Million USD | -1986.915% |
| Bio-Techne Corporation | 563.03 Million USD | 55.866% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | 39.216% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | 7.541% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -87.855% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -1624.301% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -51.799% |
| Nkarta, Inc. | 131.65 Million USD | -88.75% |
| BioCardia, Inc. | 12.12 Million USD | -1950.07% |
| Iterum Therapeutics plc | 47.46 Million USD | -423.487% |